DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
127 hedge funds and large institutions have $51M invested in DermTech, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 26 closing their positions.
198% more call options, than puts
Call options by funds: $1.75M | Put options by funds: $589K
0% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 36
5% less funds holding
Funds holding: 134 → 127 (-7)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
48% less capital invested
Capital invested by funds: $97.7M → $51M (-$46.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$1.12M |
| 2 |
AIA
Avalon Investment & Advisory
Houston,
Texas
|
+$585K |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
+$572K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$544K |
| 5 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$461K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$9.45M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$6.05M |
| 3 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$5.22M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.87M |
| 5 |
Two Sigma Investments
New York
|
-$1.55M |
DMTK Hedge Fund Activity: Q3 2022 in Review
127 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q3 2022, worth a combined $51M — down 48% from $97.7M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of DMTK and 19 opened new positions — a net loss of 7 holders — while 36 trimmed existing stakes and 36 added.
The largest buyer was Millrace Asset Group, adding an estimated $1.12M. The largest seller was UBS O'Connor, cutting an estimated $9.45M.
- 127 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q3 2022, down from 134 in Q2 2022.
- Funds reported $51M of DermTech, Inc. Common Stock stock for Q3 2022, down 48% quarter-over-quarter.
- 19 funds opened new DermTech, Inc. Common Stock positions in Q3 2022 and 26 closed out, a net change of -7 holders.
- The largest DermTech, Inc. Common Stock buyer in Q3 2022 was Millrace Asset Group, an estimated $1.12M added.
- The largest DermTech, Inc. Common Stock seller in Q3 2022 was UBS O'Connor, an estimated $9.45M sold.
Based on aggregated 13F filings for Q3 2022.